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Angiogenesis assays are essential for studying aspects of neovascularisation and angiogenesis and 
investigating drugs that stimulate or inhibit angiogenesis. To date, there are several in vitro and in vivo 
angiogenesis assays that are used for studying different aspects of angiogenesis. Although in vivo 
assays are the most representative of native angiogenesis, they raise ethical questions, require 
considerable technical skills, and are expensive. In vitro assays are inexpensive and easier to perform, 
but the majority of them are only two-dimensional cell monolayers which lack the physiological 
relevance of three-dimensional structures. Thus, it is important to look for alternative platforms to 
study angiogenesis under more physiologically relevant conditions in vitro. 
Accordingly, in this study, we developed polymeric vascular networks to be used to study angiogenesis 
and vascularisation of a 3D human skin model in vitro. Our results showed that this platform allowed 
the study of more than one aspect of angiogenesis, endothelial migration and tube formation, in vitro 
when combined with Matrigel®. We successfully reconstructed a human skin model, as a 
representative of a physiologically relevant and complex structure, and assessed the suitability of the 
developed in vitro platform for studying endothelialisation of the tissue-engineered skin model.
Keywords: angiogenesis, vascularisation, 3D model, angiogenesis model, tissue engineering, skin, 
tissue-engineered skin model
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Angiogenesis is a sophisticated process regulated by a complex web of interactions of endothelial cells 
(ECs) with their extracellular matrix (ECM) and with biochemical and mechanical factors 1. The delayed 
neovascularisation of tissue-engineered (TE) constructs post-implantation can cause them to fail 
clinically 2. Thus, investigating the factors that regulate angiogenesis is particularly important to 
understand how they are involved in this complex process. 
Angiogenesis assays are powerful tools to study aspects of angiogenesis and can be categorised into 
three main categories: (i) in vitro, (ii) ex vivo, and (i) in vivo 3. In vivo assays are the most representative 
of native angiogenesis, but since healthy animals are used to perform these assays, they are ethically 
questionable, require considerable technical skills, and expensive 4. In contrast, in vitro assays are 
inexpensive and relatively easy to perform. However, the majority of them are based on two-
dimensional (2D) cell culture systems which lack the physiological relevance that three-dimensional 
(3D) structures can provide 5. Thus, it is important to develop better in vitro platforms that enable the 
study of angiogenesis under more physiologically relevant conditions. 
Several in vitro angiogenesis models fabricated by combining several methods including Bio-MEMS 6, 
3D printing and porogen leaching 7,8, 3D printing and electrospinning 9,10 have previously been 
reported. However, most of them rely on the use of natural gels and allows the evaluation of 
angiogenesis at only the cellular level. Although these natural gels are biologically preferable by 
endothelial cells in terms of providing an improved cell attachment, proliferation and sprouting 11, the 
use of natural materials limits control over degradability, formability, and mechanical properties. 
Skin is the largest organ in the body and acts as a physical barrier between the body and the external 
environment. It is composed of histologically definable three main layers: the epidermis, the dermis 
and the hypodermis. In the cellular level, keratinocytes are the most common type of cells located in 
the epidermal layer of the skin, and they form different layers of the epidermis with different tasks. 
Fibroblasts, the second common type of cells in skin, are located in the dermal layer and provide 
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physical strength as well as elasticity of skin 12,13. Skin tissue engineering has gained great momentum 
over the years. However, developing biologically relevant in vitro tissue models as alternatives to 
animal models or as physiologically relevant tissue substitutes for clinical use is always open for 
improvement. 
Several in vitro skin models have been developed by many groups or companies over the years to 
study different subjects such as being alternatives to animal testing, wound healing, pigmentation, 
contraction, tumour invasion, barrier function, and bacterial infection studies 12,14. Facy et al. created 
a reconstructed epidermis model with Langerhans cells and used this model to test the reactivity of 
these cells to known allergens and UV 15. Kandarova et al. studied skin irritation using two 
reconstructed human skin equivalents as an alternative to animal testing 16. To study pigmentation, 
Bessous et al. developed an in vitro reconstructed epidermis using autologous keratinocytes and 
melanocytes 17. Meier et al. developed a human skin equivalent to study melanoma progression, and 
they reported a close correspondence between the growth of melanoma into engineered skin 
construct and in vivo 18. Admane et al. reported the direct 3D bioprinting of full-thickness skin 
constructs that mimics the signalling pathways of skin 19. Similarly, Kim et al. developed a 3D printed 
skin model with perfusable vascular channels to create a vascularised skin model 20. Kolesky et al. 
developed a platform using a multi-material 3D bioprinting method, which enables researchers to 
create thick tissue models with engineered matrix and embedded vasculature 21. Recently, John et al. 
demonstrated the regeneration of TE skin substitute on human amniotic membrane 22. Our laboratory 
has previously reported a 14-day protocol for the reconstruction of a 3D human skin model that is 
suitable for clinical use 23, and have previously explored adding Human Dermal Microvascular 
Endothelial Cells (HDMEC) to TE skin model with very little success-the cells struggled to enter the TE 
skin and showed no signs of being organised when they did enter 24. Although TE skin was being 
studied for a long time to be used as skin substitutes in the clinic or in vitro models for research, the 
main challenge remains the same: studying and improving angiogenesis/vascularisation of a TE skin 
for translation of it to clinic or for doing research on understanding the basic principles of skin 
Page 3 of 58
ACS Paragon Plus Environment






























































vascularisation. Either for implanting or for in vitro laboratory research, developing a vascularised 3D 
human skin model is highly important for the successful take of TE skin substitute after implantation 
or studying the effect of chemical, mechanical and environmental factors on neovascularisation of 
skin. Thus, there is a need to develop new platforms that enable to study vascularisation of complex 
tissues such as skin. 
Accordingly, in this study, we fabricated synthetic vascular networks (SVN) made of Poly-3-
hydroxybutyrate-co-3-hydroxyvalerate (PHBV), a biocompatible and biodegradable polyester, 
combining electrospinning and 3D printing techniques to study angiogenesis in a physiologically more 
relevant environment and to investigate the vascularisation of a reconstructed human skin model. The 
main aim of this study was to create a unique in vitro platform that enables researchers to study more 
than one aspect of angiogenesis both at cellular and tissue levels. PHBV channels were used as physical 
support and a structural guide for ECs to create a pre-formed endothelium-like structure. This 
endothelium-like structure was then used to study the migratory response and tube-forming 
capability of ECs in response to pro-angiogenic agents in vitro and to explore how synthetic channels 
can be used as a model for the vascularisation studies at tissue level. The chick chorioallantoic 
membrane (CAM) assay has been used for the first time as a surrogate for a well-vascularised wound 
bed to provide the source of blood vessels to grow into the 3D human skin as a positive control to the 
PHBV SVN vascularisation studies.
2. Experimental
2.1. Materials
2-deoxy-D-ribose (2dDR), 37% formaldehyde (FA) solution, 4',6-diamidino-2-phenylindole (DAPI) 
solution, Adenine, AlamarBlue Cell Metabolic Activity Assay, Alginic acid sodium salt, Amphotericin B, 
Anti-CD31 (PECAM-1) antibody produced in mouse, Bovine serum albumin (BSA), Calcium chloride 
dihydrate, Chlorotoxin, Collagenase A, D-glucose, Dimethyl sulphoxide (DMSO), Dulbecco’s Modified 
Eagle’s Medium (DMEM), Ethylenediaminetetraacetic acid (EDTA), Eosin Y solution, Ethanol, F-12 
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HAM nutrient mixture, Fetal calf serum (FCS), Fibrinogen from human plasma, Glutaraldehyde (25%), 
Glycerol, Hematoxylin solution, Hydrocortisone, Insulin (human recombinant), L-glutamine, 
Methylene blue, Penicillin / Streptomycin, Phalloidin, #fluorescein isothiocyanate (FITC), Phalloidin, 
tetramethylrhodamine isothiocyanate (TRITC), Sodium hydroxide pellets, Trypan blue, Trypsin EDTA, 
Tween®20, Vascular endothelial growth factor (VEGF), and Sodium chloride (NaCl) were purchased 
from Sigma Aldrich. Dichloromethane (DCM), DPX mounting medium, Industrial methylated spirit 
(IMS), Methanol, Triton X-100, and Xylene were purchased from Fisher Scientific. Human Dermal 
Microvascular Endothelial Cells (HDMECs), Endothelial Cell Growth Medium MV (EC GM) and EC GM 
Microvascular (MV) Supplement Pack were purchased from PromoCell. CellTracker™ Green, 
CellTracker™ Red, and Alexa Fluor 546 Goat anti-Human IgG (H+L) Cross-Adsorbed Secondary 
Antibody were purchased from ThermoFisher. Poly-3-hydroxybutyrate-co-3-hydroxyvalerate (12%) 
(PHBV) was purchased from GoodFellow. Matrigel® (Growth Factor Reduced) was purchased from 
Corning. Thrombin (human) was purchased from Cayman Chemical. Epidermal growth factor (EGF) 
was purchased from R&D systems. Optimum cutting temperature tissue freezing medium (OCT-TFM) 
was purchased from Leica Biosystems.
2.2. Methods
2.2.1. Manufacturing of the SVN made of PHBV
The channels of the SVN was designed using computer-aided design (CAD) software (SolidWorks 2012, 
Massachusetts, USA). Following the 3D design of SVN channels, scaffolds were manufactured via the 
four-step process, as shown by Figure 1. 
Alginate was then used as a sacrificial substrate and 3D printed on to PHBV using a 3D bioprinter 
(BioBots, Philadelphia, USA). Following that, another layer of PHBV was electrospun on top of the 
alginate using same parameters. Finally, alginate was removed via EDTA solution.
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Figure 1. Schematic illustration showing the four-step manufacturing process of synthetic vascular channels. (A) 
Electrospinning PHBV, (B) 3D printing of the sacrificial alginate channels, (C) electrospinning another layer of 
PHBV on top of alginate channels, and (D) removal of alginate.
2.2.1.1. Electrospinning PHBV
First, PHBV (10% (w/w)) granules were dissolved in DCM:methanol (90:10 w/w) solvent blend in a 
fume hood. PHBV polymer solution (~5 ml) was loaded into 5 ml syringes fitted with 0.6 mm inner 
diameter syringe tips. Syringes were then placed in a syringe pump (GenieTMPlus, KentScientific, 
Connecticut, USA). Aluminium foil was used as the collector and placed at a distance of 17 cm from 
the needle tips. The pump was set to 40 µl/minute, and 17 kV voltage was applied both to the collector 
and the tips. The polymer was electrospun on the collector with the parameters given above for an 
hour.
2.2.1.2. 3D printing of alginate as a sacrificial material
1.5 % alginate paste was produced by dissolving 0.2 g of calcium chloride dihydrate (CaCl2.2H2O) into 
a 72.7 g of distilled water (dH2O) while continuously stirring using a magnetic stirrer. The solution was 
then heated to approximately 60°C before adding 1.5 g of alginic acid sodium salt while continuously 
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stirring on a hot plate magnetic stirrer. Once it was fully dissolved and dehydrated, 24.25 g of glycerol 
was added and stirred until a smooth viscous paste was obtained.
Prior to 3D printing, the desired numbers of 3D models were oriented and sliced using g-code 
generator software (Repetier-Host, Willich, Germany). The model was then exported as g-code using 
the following parameters: 0.4 mm layer height, 0.4 mm nozzle diameter and 2 mm/s speed. The 
alginate paste was transferred into a 10 ml syringe with 0.4 mm blunt tip, and the syringe was inserted 
to the extruder of 3D bioprinter. The aluminium foil containing electrospun PHBV layer was placed 
onto the lid of a 6-well plate and fixed using adhesive paper tape. G-code was then uploaded to the 
3D printing software (Bioprint, Philadelphia, USA), and the pressure was adjusted between 11-20 psi. 
Finally, the extruders were calibrated, and the alginate was 3D printed on the PHBV electrospun sheet. 
Following the 3D printing process, the electrospinning process was repeated using the same 
parameters to create synthetic vascular channels inside two layers of PHBV.
2.2.1.3. Removal of alginate
0.5 M EDTA solution was prepared in dH2O. The pH was then adjusted to 8.0 by adding sodium 
hydroxide (NaOH) beads whilst stirring continuously.
The scaffolds were submerged in 0.5 M EDTA solution overnight on a shaker (Fisher Scientific, 
Massachusetts, USA) set to 70 oscillations / minute to create hollow channels between two layers of 
PHBV sheets by removing alginate. Two ends of the scaffolds were cut to allow alginate to be removed 
prior to submerging it into EDTA solution.
2.2.2. Characterisation of the PHBV SVN
2.2.2.1. Scanning Electron Microscopy (SEM)
The surface morphology and the cross sections of PHBV SVN were observed under SEM (Philips/FEI 
XL-20 SEM; Cambridge, UK). The samples were coated with gold using a gold sputter (Edwards sputter 
coater S150B, Crawley, England) prior to imaging. Average fibre diameter and pore size were 
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measured using ImageJ software (Wayne Rasband, National Institutes of Health, USA) as described 
previously 25.
2.2.2.2. Biomechanical testing of PHBV SVN
Tensile testing was carried out for the dry and wet scaffolds using a uniaxial mechanical testing 
machine (BOSE Electroforce Test Instruments, Minnesota, USA) equipped with a 22 N load cell. 
Scaffolds were submerged in PBS for 1 hour before testing to be wetted. The clamps of the device 
were positioned 15 mm away from each other, and the width and thickness of each scaffold were 
measured. Test samples either dry or wet were clamped with two grips in a tensiometer. Tensile tests 
were performed on each sample at a rate of 0.1 mm/s until the samples fail. The raw data of the tests 
were taken and tabulated before converting them into stress-strain curves. Stress and strain values 
were calculated using Equation 1 and 2:
𝑆𝑡𝑟𝑒𝑠𝑠 (𝑀𝑃𝑎) =  𝐹𝑜𝑟𝑐𝑒 (𝑁)𝐴𝑟𝑒𝑎 (𝑚𝑚2) (1)
𝑆𝑡𝑟𝑎𝑖𝑛 =  𝐿𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑠𝑡𝑟𝑒𝑡𝑐ℎ (𝑚𝑚)𝑂𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑙𝑒𝑛𝑔𝑡ℎ (𝑚𝑚) (2)
Ultimate tensile strength (UTS), yield strength (YS) and stiffness parameters were calculated 
using stress (σ) and stress (ε) curves of each sample. 
Suture retention tests were performed based on the BS EN ISO 7198:2017, which is the standard for 
testing vascular grafts and patches. Before clamping the samples to a uniaxial testing device, scaffolds 
were sutured from 2 mm away from the upper end with a suture (Ethicon, New Jersey, USA) which is 
for use in general soft tissues. The distance between clamps was then adjusted, and the tests were 
conducted at a rate of 0.1 mm/s until the samples fail. Suture retention strength was calculated using 
Equation 3:
𝑆𝑢𝑡𝑢𝑟𝑒 𝑅𝑒𝑡𝑒𝑛𝑡𝑖𝑜𝑛 (𝑀𝑃𝑎) =  𝑆𝑢𝑡𝑢𝑟𝑒 𝑅𝑒𝑡𝑒𝑛𝑡𝑖𝑜𝑛 𝐹𝑜𝑟𝑐𝑒 (𝑁)𝑆𝑢𝑡𝑢𝑟𝑒 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 (𝑚𝑚)𝑥 𝑇ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠 (𝑚𝑚) (3)
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2.2.3. Cannulation of the PHBV SVN to test the channel structure and patency
Prior to cell seeding into PHBV SVN, channels were cannulated with a 25 G cannula by perfusing PBS 
into the channels under a dissection microscope (Wild Heerbrugg, Heerbrugg, Switzerland). 
Methylene blue was then injected into channels to visualise the channel structure and patency using 
a 25 G cannula and the images of the channels were obtained under dissection microscope.
2.2.4. Cellularisation of synthetic scaffolds
For cellularisation of the PHBV SVN, two different procedures were assessed: (i) HDMECs were seeded 
into the channels in isolation and (ii) HDMECs were seeded into the channels whereas Human Dermal 
Fibroblasts (HDFs) were seeded to the outer surfaces of the channels.
2.2.4.1. Cellularisation of the PHBV channels with HDMECs in isolation
The PHBV SVN was disinfected by submerging them in 70% ethanol for 45 minutes and then washed 
three times with PBS prior to cell seeding and transferred to petri dishes. HDMECs were used between 
passage 2-4. Once they reached 80-90% confluency, 0.5 x 106 HDMECs were resuspended in 0.25 ml 
of EC GM (supplemented with 2% FCS, 0.4% EC growth supplement, 10 ng/ml EGF, 90 µg/ml heparin, 
1 µg/ml hydrocortisone) and then perfused into the SVN using a 1 ml syringe with a 25 G cannula. 
Before adding culture medium, scaffolds were returned to the incubator for an hour to allow HDMECs 
to attach to the inside of the channels. Then, 10 ml of HDMECs culture medium was added to each 
petri dish, and they were incubated at 37°C overnight. Scaffolds were flipped over, and the same 
seeding process was repeated in order to cellularise the other side of the channels on the following 
day. Scaffolds were kept in culture for 7 days by changing the culture medium every 2-3 days. The 
PHBV SVN scaffolds were fixed in 3.7% FA. Fixed scaffolds were then embedded in freezing medium 
and frozen in liquid nitrogen for 3 minutes. Sections were cut 5-10 µm thick using a cryostat (Leica 
Biosystems Nussloch, Germany) and stained with hematoxylin & eosin (H&E) as described previously 
26,27. Briefly, the slides were stained with hematoxylin for 5 minutes and eosin for 90 seconds prior to 
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dehydration with serial alcohol washes. The slides were then mounted with DPX mountant and 
investigated under a light microscope (Motic BA210, China).
2.2.4.2. Cellularisation of the PHBV channels with HDMECs and HDFs 
HDMECs were used between passage 2-4. HDFs were used between passage 2-6, once cells reached 
80-90% confluency. The PHBV SVN was disinfected by submerging them in 70% ethanol for 45 minutes 
and then washed three times with PBS prior to cell seeding. To be able to image them separately under 
a fluorescent microscope, each cell type was marked using CellTracker™ Fluorescent Probes. To label 
the HDMECs, 50 µg of CellTracker™ Red dry powder was dissolved in 7.3 µl of DMSO. Then 3 ml of 
serum-free HDMECs culture medium was added to prepare a ~25 µM working dye solution. The pre-
warmed dye solution was then added gently to T75 flask, and HDMECs were incubated for 1 hour 
under growth conditions. To label the HDFs, 50 µg of CellTracker™ Green dry powder was dissolved in 
10.75 µl of DMSO. Then 4.3 ml of serum-free HDFs culture medium was added to prepare ~25 µM 
working dye solution. The pre-warmed dye solution was then added gently to T75 flask, and HDFs 
were incubated for 1 hour under growth conditions. Following the labelling of cells, sterile scaffolds 
were transferred to petri dishes. 0.5 x 106 HDMECs were trypsinised, centrifuged and resuspended in 
0.25 ml of culture medium and then perfused into the synthetic vascular channels using 1 ml syringe 
with 25 G cannula. Following that, 0.5 x 106 HDFs were trypsinized, centrifuged and resuspended in 
200 µl of HDMEC growth medium and pipetted on the outer surface of the channels. Before 
submerging the scaffolds into HDMECs culture medium, scaffolds were incubated at 37°C for up to 2 
hours in order to allow HDFs to be attached on the outer surface. Then, 10 ml of HDMECs culture 
medium was added to each petri dish, and they were incubated at 37°C overnight. Scaffolds were 
flipped over, and the same CellTracker™ labelling and seeding protocol was followed in order to 
cellularise the other side of the channels on the following day. Scaffolds were kept in culture for 7 days 
by changing the culture medium every 3 days. 
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In order to verify the presence and check the distribution of the HDMECs within the PHBV vascular 
channels prior to further experiments, scaffolds were fixed in 3.7% FA and 5-10 µm thick sections were 
taken as described in Section 2.2.4.1 and immunostained for the expression of CD31 and 
counterstained with DAPI after 7-day culture of HDMECs and HDFs in PHBV SVN. Briefly, a hydrophobic 
barrier pen was used to draw circles around each sample on the slide in order to create a water 
repellent barrier which creates a reservoir on sections for staining reagents. Cells were permeabilised 
by incubating in 0.1% Triton-X 100 for 20 minutes at room temperature (RT) and then in 7.5% BSA at 
room temperature for 1 hour to block unspecific binding of the antibodies. This step was followed by 
washing once with 1% BSA, and the samples were incubated with the appropriate primary antibodies 
diluted in 1% BSA (1:50 dilution was used for Anti-CD31 primary antibody) at 4 °C overnight. Next day, 
samples were washed 3 times with PBS before incubating with the appropriate secondary antibodies 
diluted in 1% BSA (1:500 dilution is used for AlexaFluor®546 conjugated secondary antibody) at RT for 
1 hour and washing three times with PBS. Samples were counterstained with DAPI solution by 
incubating for 20 minutes at RT. Slides were then washed three times with PBS and imaged using a 
fluorescent microscope (Olympus IX3, Tokyo, Japan). 
2.2.5. Fluorescent staining 
For PHBV SVN recellularised with HDMECs in isolation, the scaffolds were fixed in 3.7% FA for 1 hour 
and sectioned using a cryostat as described in Section 2.2.4.1. For analysing the of the cells in the 
PHBV SVN, the sections were stained with Phalloidin-TRITC (1:500 diluted in PBS) (or Phalloidin-FITC 
(1:500 diluted in PBS) in some of the experiments) to stain cytoskeleton. Sections were then stained 
with DAPI (1:1000 diluted in PBS) to stain cell nuclei. Briefly, 0.1% (v/v) Triton X 100 (in PBS) was added 
on samples, and the samples were incubated for 20-30 minutes at room temperature. After three 
times washing with PBS, either Phalloidin solution was added to cells and incubated for 30 minutes at 
RT at dark. Sections were then washed three times with PBS. DAPI solution was then added and 
incubated for 10-15 minutes at RT in the dark, and the cells were then washed 3 times with PBS. 
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Finally, DPX mountant was pipetted onto the samples, and samples were covered with a coverslip. 
Cells were then examined under a fluorescent microscope.
2.2.6. Direct imaging of pre-labelled cells
While investigating HDMECS in co-culture with HDFs, cells were pre-labelled using CellTracker™ 
Fluorescent Probes with the intent of distinguishing them during fluorescent imaging. Use of 
fluorescent probes prior to cultivating cells in the scaffolds enabled us to image HDMECs and HDFs 
directly under a fluorescent microscope following the sectioning step. 
2.2.7. Development of a 3D TE skin model
2.2.7.1. Isolation of human foreskin keratinocytes and HDFs from skin grafts
Skin grafts were obtained from patients who were informed of the use of their skin for research 
purposes according to a protocol approved by the Sheffield University Hospitals NHS Trust Ethics 
Committee. Fibroblasts and keratinocytes were isolated from the skin, as described by Ghosh et al. 28. 
Briefly, skin samples were cut into 0.5 cm2 pieces and incubated overnight in Difco-trypsin (0.1% (w/v) 
trypsin, 0.1% (w/v) D-glucose in PBS, pH 7.45) before being washed and maintained in PBS. 
For isolating keratinocytes, skin samples were taken from the solution and transferred into a petri dish 
filled with growth media. The epidermis was peeled off, and the surface of the epidermis (papillary 
surface) was gently scraped, and basal keratinocytes were collected into the growth media. Cells were 
then harvested by centrifuging at 1000 rpm for 5 minutes, resuspended and seeded into 75 cm2 tissue 
culture flasks with the presence of a feeder layer (irradiated mouse 3T3 (i3T3) cells) and cultured in 
Green’s media (66% DMEM (v/v), 21.6% F12-HAMS (v/v), 10% FCS (v/v), 0.5% insulin, 0.5% adenine, 
0.1% T/T, 0.1% chlorotoxin, 0.016% hydrocortisone, 0.01% EGF, 100 IU ml–1 penicillin, 100 µg ml–1 
streptomycin, 2mM L-glutamine and 0.625 µg ml−1 amphotericin B).
Page 12 of 58
ACS Paragon Plus Environment






























































HDFs were isolated by mincing the dermis with into 10 mm2 pieces. The pieces were then incubated 
overnight at 37 °C in 0.5% (w/v) collagenase A solution. The suspension of fibroblasts was centrifuged 
at 1000 RPM for 5 minutes and resuspended in DMEM containing 10% (v/v) FBS, 100 IU ml–1 penicillin, 
100 µg ml–1 streptomycin, 2mM L-glutamine, and 0.625 µg ml−1 amphotericin B.
2.2.7.2. Preparation of acellular de-epidermised dermis (DED)
DED was prepared from skin grafts according to a modified method described by Chakrabarty et al. 29. 
Briefly, the skin graft was treated in 1 M NaCl solution for 24 hours at 37°C and then washed with PBS 
for 40 minutes. The epidermis was removed by peeling off or scraping gently (if epidermal layer 
remains, and cells have not been harvested before). DED was kept in Green’s media at 37°C for 2 days 
to check its sterility. 
2.2.7.3. Construction of a 3D TE human skin model
A 3D human skin model was reconstructed in vitro to study vascularisation of the skin using a well-
established protocol 23. Briefly, 1 cm2 pieces were cut from DED, and a stainless-steel ring (0.79 cm2) 
was placed onto the papillary side. HDFs were trypsinized and centrifuged at 1000 RPM for 5 minutes 
before being resuspended in DMEM. 1 x 105 HDFs were seeded into the stainless-steel ring and kept 
in 37°C while preparing keratinocytes for seeding. The i3T3 feeder layer was removed first using 5 ml 
of 0.5 M sterile EDTA solution with 3-5 minutes incubation at 37°C. After removal of the feeder layer, 
keratinocytes were then trypsinized and centrifuged at 1000 RPM for 5 minutes and resuspended in 
Green’s media. 3 x 105 HDFs were seeded into the stainless-steel ring as a co-culture with HDFs. TE 
skin models were incubated overnight at 37°C before removing the ring and addition of Green’s media. 
3D skin models were incubated in Green’s media for another day (two days in total) and then raised 
to the air-liquid interface by using a sterile stainless-steel grid and cultured for a total of 14 days in 
order to ensure differentiation of the layers of the epidermis. 
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2.2.8. Use of the PHBV SVN to study angiogenesis in vitro and to investigate the vascularisation 
of a reconstructed skin model
Two separate experiments were designed to investigate the potential of the developed PHBV SVN to 
be used as an in vitro platform to study angiogenesis and vascularisation of a TE skin model: (i) 
Matrigel® outgrowth experiments and (ii) TE skin vascularisation studies (Figure 2).
Figure 2. Experiments showing the investigation of the potential of the PHBV SVN to be used as an in vitro 
platform to study angiogenesis and vascularisation of a TE skin model. Purple dotted lines represent pierced holes. 
Matrigel® and TE skin are indicated with blue and orange colors, respectively.
2.2.8.1. Investigating the endothelial outgrowth from PHBV channels to Matrigel®
For Matrigel® outgrowth experiments, PHBV SVN repopulated with HDMECs (1x106 HDMECs per 
scaffold) were incubated for 7 days as described in Section 2.2.4.1. Once a uniform monolayer of 
HDMECs was obtained, escape holes were pierced on the channels. The piercing procedure was 
performed as described previously 30. Approximately 100 equally distanced holes per scaffold were 
created in random orientations (from top and sides) to cover the surface of all channels as evenly as 
possible using sterile 30 G syringe needle. The final concentrations of VEGF and 2dDR within the 
Matrigel® were 80 ng/ml and 1.34 μg/ml respectively. 100 μl of Matrigel® was pipetted into hexagonal 
wells formed by synthetic channels and 200 μl into the well between two hexagonal wells. Scaffolds 
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were then returned to the incubator for Matrigel® to set at 37 °C for 15 minutes. PHBV scaffolds were 
then submerged in HDMEC culture medium and cultured for 7 days.
For analysing the HDMEC outgrowth through Matrigel® after culturing HDMECs in the synthetic PHBV 
vascular scaffolds, the scaffolds were fixed and stained with Phalloidin-TRITC and DAPI as described 
previously. As the scaffolds were opaque and too thick to image directly, they interfered with the 
visualisation of the cellular outgrowth and tube formation when the Matrigel® was in place. Thus, the 
Matrigel® was peeled off from the surface of the PHBV SVN, and fluorescent images were taken within 
the Matrigel® close to the edges of the PHBV SVN to investigate the tube formation and the branching. 
The formation of the tubes can be defined as the gradual formation of capillary-like tubular structures 
by the ECs in response to pro-angiogenic stimulants, and connected capillary-like tubes to each other 
form a mesh-like structure within the gel. These mesh-like structures are maintained for 
approximately 24 hours. Each closed loop (mostly pentagonal or hexagonal loops) formed by ECs 
within the gel is defined as a tube-like structure, and the branch sites/nodes are defined as branching 
points. The number of tubes and branch points are two widely used measures of in vitro angiogenesis 
when conventional tube formation assays are used 31. Accordingly, we quantified the total number of 
tubes and the branch points per field of view as described previously using Angiogenesis Analyzer 
plugin of ImageJ 32 and AngioTool software 30, respectively.
2.2.8.2. Investigating the endothelial outgrowth from PHBV channels to reconstructed 
skin model
For skin vascularisation experiments, PHBV synthetic vascular scaffolds populated with HDMECs 
(1x106 HDMECs per scaffold) and HDFs (1x106 HDMECs per scaffold) were incubated for 7 days as 
described in Section 2.2.4.2, and the cellularised scaffolds were then transferred into 6-well plates in 
class II biological safety cabinet. Using sterile 30G syringe needle holes were pierced on the channels. 
TE skin models were prepared as described in section 2.2.7 and cut circular at day 7 prior to 
implantation. Fibrin glue was used to glue TE skin to PHBV SVN. Use of fibrin glue in skin grafts and TE 
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skin replacements has previously been reported 33. Fibrin glue was prepared by mixing fibrinogen from 
human plasma (20 mg/ml in 0.9% NaCl solution in dH2O) and human thrombin (25 units/ml in 0.1% 
BSA). Briefly, 50 μl of fibrinogen was pipetted over the surface of the PHBV SVN channels. Then 50μl 
of thrombin was pipetted over fibrinogen, and TE skin models were glued immediately on channels. 
PHBV scaffolds with TE skin models on them were then submerged in EC GM either supplemented 
with 80 ng/ml VEGF or non-supplemented (control) and cultured for a further 7 day at the air-liquid 
interface. Throughout the experiment duration, EC GM either non-supplemented or supplemented 
with VEGF (80 ng/ml) was pipetted from the top of the TE skin model twice per day.
For the investigation of the HDMEC outgrowth through reconstructed TE skin models, scaffolds with 
TE skin on top of them were fixed in with 3.7% FA. Fixed PHBV scaffolds with TE skin models were then 
embedded in OCT freezing medium and frozen in liquid nitrogen for 3 minutes. The scaffolds were 
sectioned 5-10 µm thick using a cryostat (Leica Biosystems Nussloch, Germany) at -20°C and 
permeabilised with 0.1% Triton-X100 for 30 minutes. The sections were then immunostained for anti-
CD31 and counterstained with DAPI as described in Section 2.2.4.2. The sections were further 
investigated histologically by staining the sections with haematoxylin for 1.5 minutes and eosin for 5 
minutes. The outgrowth distance of HDMECs was determined using ImageJ software, and the results 
were then statistically analysed using GraphPad Prism software.
2.2.9. Investigating the vascularisation of the TE 3D skin equivalent using ex-ovo CAM assay 
Ex-ovo CAM assay was used to evaluate the vascularisation of the TE skin model as a positive control. 
A video protocol of ex ovo CAM assay has been reported previously by our group 34. Briefly, fertilised 
chicken eggs (Gallus domesticus) were purchased from Henry Stewart & Co. MedEggs (Norwich, UK) 
and cleaned with 20% IMS solution. Eggs were incubated at 37.5°C for 3 days in a rocking egg incubator 
(RCOM King SURO, P&T Poultry, Powys, Wales). On day 3, the embryos were transferred gently into 
sterile petri dishes and incubated at 38°C in a cell culture incubator (Binder, Tuttlingen, Germany). 
CAM assay was conducted in care of the guidelines of the Home Office, UK. On day 7, reconstructed 
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human skin equivalents (14-day cultured) were cut circular (8 mm diameter) using a biopsy punch and 
implanted to CAMs for a further 7 days. In order to study the effect of proangiogenic drugs, VEGF and 
2dDR were added twice a day dropwise throughout the assay duration. The concentrations of the 
drugs were 80 ng/day/embryo and 200 µg/day/embryo for VEGF and 2dDR, respectively. 
Macro images of the reconstructed skin equivalents implanted on CAM were taken using a digital USB 
microscope at embryonic development day 14. Embryos were then euthanised, and the skins cut with 
a rim of surrounding CAM tissue and fixed in 3.7% FA solution. Angiogenesis was quantified by 
counting all blood vessels growing towards the scaffolds in a spoke wheel pattern, as described 
previously 25. Histological analysis of the samples was performed with H&E staining as described 
previously in Section 2.2.4.1.
2.2.10. Statistical analysis
Statistical analysis was carried out using either one-way or two-way analysis of variance (ANOVA) using 
statistical analysis software (GraphPad Prism, CA, USA). Where relevant, n values are given in figure 
captions. Error bars indicate standard deviations in the graphs unless otherwise stated.
3. Results
3.1. Results of the characterisation of the PHBV SVN
3.1.1. Macrostructure and microstructure of the PHBV SVN and the confirmation of the channel 
patency
Combination of electrospinning and 3D printing allowed the production of a number of replicate 
scaffolds in a short period of time (in less than 2 hours). The SEM images of the PHBV SVN showed 
that it was possible to obtain a connected network of hallow channels after removal of the alginate. 
The PHBV SVN scaffolds used in this study were approximate ~30 mm in length and ~18 mm wide with 
the elongated hexagonal shapes. For each production batch, approximately 12 scaffolds were 
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produced, and 100% of these was used. The macrostructure and the microstructure of the PHBV SVN 
scaffolds before alginate removal were given in Figure 3A. The removal of alginate was confirmed by 
the cannulation of the PHBV SVN with methylene blue dye and with the SEM imaging of the open 
channel structure. The injection of methylene blue through the channels showed that the dye reached 
all the channels within the network. The highly packed structure of the nanofibrous electrospun fibres 
allowed the retaining of the dye inside of the channels, and the channels were found open and 
interconnected without any leakage between the two layers of PHBV fibres and through small pores 
between fibres (Figure 3B). 
Figure 3. The macrostructure and the microstructure of the PHBV SVN scaffolds before and after removal of the 
3D printed alginate. (A) Before removal of alginate, SEM images of the channels (top view), macro image of the 
PHBV SVN (top view), and dissection microscope image of the cross section of the channels, from left to right, 
respectively. (B) After removal of alginate, dissection microscope images of the methylene blue injected channels 
(top view), macro image of the methylene blue injected PHBV SVN channels (top view), and SEM image of the 
cross section of the channels, from left to right, respectively.
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3.1.2. Mechanical Properties of the PHBV SVN
The average diameter of the fibres and the average pore size between the fibres were calculated as 
0.76 ± 0.22 µm and 2.73 ± 1.47 µm, respectively. The results of the mechanical testing of the scaffolds 
showed that the average UTS was higher under dry conditions (0.87 ± 0.14 MPa) compared to wet 
scaffolds (0.48 ± 0.12 MPa). The stiffness of the PHBV scaffolds dramatically reduced from 6.33 ± 0.59 
N/mm to 0.94 ± 0.14 N/mm when moistened. Similarly, suture retention of the scaffolds in dry state 
was double of that in the wet state (1.70 ± 0.05 MPa and 0.89 ± 0.11 MPa, respectively for dry and 
wet scaffolds). The results of the mechanical tests are summarised in Table 1.
Table 1. Morphological and mechanical properties of the PHBV SVN under dry and wet conditions. (a,dsignificantly 






























3.1.3. Cellularisation of the PHBV SVN with HDMECs in isolation
To investigate the survival of HDMECs inside the vascular channels without HDFs as supporter cells, 
HDMECs were seeded inside the PHBV SVN and cultured for 7 days under static conditions. A complete 
formation of the HDMEC monolayer within the PHBV SVN has been confirmed with fluorescent and 
H&E staining (Figure 4). 
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Figure 4. Fluorescent staining of sections taken from scaffolds recellularised with HDMECs in isolation. (A) DAPI 
(blue), (B) Phalloidin-TRITC (red) and (C) combined red and blue channels, and (D) H&E staining of the sections 
from PHBV SVN.
3.1.4. Cellularisation of the PHBV SVN with HDMECs in the presence of helper HDFs
To investigate the formation of a continuous EC monolayer inside the synthetic vascular channels, 
HDMECs were seeded inside the channels in co-culture with HDFs on the outer surface. CellTracker 
labelled and H&E stained images of the sections are given in Figure 5A-C. 
Anti-human CD31 (red) stained sections of the PHBV SVN recellularised with HDMECs inside the 
channels and HDFs on the outer surface cultured over 7-days are given in Figure 5B. The 
immunostaining showed an evenly distributed HDMEC monolayer within the channels in both curved 
and flat surfaces, whereas HDFs covering the outer surface of the scaffolds was only stained with DAPI 
(blue). 
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Figure 5. Recellularisation of the PHBV SVN with HDMECs and HDFs in indirect contact. (A) H&E staining of the 
HDMECs inside the channels and HDFs on the outer surface. (B) Immunostained sections of PHBV synthetic 
vascular scaffolds recellularised with HDMECS within the channels and HDFs on the outer surface. Cell nuclei was 
stained with DAPI (blue) and CD31+ cells were shown with red. (C) Sections of scaffolds with HDMECs labelled 
with CellTracker™Red inside the channels and HDFs labelled with CellTracker™Green on the outer surface of the 
scaffolds. 
3.2. Use of the PHBV SVN to study angiogenesis in vitro: results of HDMEC outgrow from 
PHBV SVN to Matrigel®
The results of the Matrigel® outgrowth experiments showed that HDMECs were observed as 
outgrowing and forming interconnected tube-like structures within the Matrigel® close to edges of 
the pierced synthetic PHBV channels by day 7 (Figure 6). Inclusion of both pro-angiogenic agents, 2dDR 
and VEGF, increased the formation of tube-like structures. However, tube-like structures were more 
obvious and well-organised in VEGF loaded Matrigel® groups when compared with 2dDR loaded and 
control groups. Although these experiments were repeated 3 times, and 5 replicates were used for 
each repeat, it is important to note that the formation of tube-like structures was witnessed only 20% 
of the experiments for VEGF loaded Matrigel® and 13.3% of the 2dDR loaded and control groups.
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Figure 6. The figure shows the outgrowing HDMECs from PHBV channels to either plain or VEGF or 2dDR loaded 
Matrigel®. The ECs were stained with Phalloidin-TRITC (red) to visualise actin filaments and counterstained with 
DAPI (blue) to visualise the cell nuclei. Tube-like formed structures were obvious and well-organised in VEGF 
loaded Matrigel® groups when compared with 2dDR loaded and control groups. The graphs show the increase 
in the number of tubes formed (on the left) and branch points (on the right) within Matrigel® when VEGF and 
2dDR were loaded. (***p≤0.001, *p ≤ 0.05).
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The quantification of the fluorescent images showed that inclusion of 2dDR and VEGF in Matrigel® 
increased the number of tubes formed per field within the gel up to 3.5 ± 1.1 and 8.2 ± 4.0, respectively 
where the number of tubes per field was 1.0 ± 0.9 in control group. Similarly, average branch points 
were increased from 3.1 ± 1.9 (control) to 12.3 ± 4.4 and 27.6 ± 8.2, respectively, when 2dDR and VEGF 
loaded to Matrigel®. 80 ng/ml VEGF was found significantly more effective for stimulating tube 
formation and for increasing branch points when compared to 100 µM 2dDR.
3.3. Use of the PHBV SVN to study vascularisation of a TE skin model
3.3.1. General appearance and histological evaluation of the 3D TE skin models
The macro evaluation of the developed skin model showed that the colour of the circular area seeded 
with HDFs and keratinocytes started to change to a yellowish colour which identifies the formation of 
a new epithelium on DED. The histological evaluation of the reconstructed TE skin models showed 
that developed TE skin model achieved a normal-looking gross skin morphology in 14 days. A multi-
layered epithelium was formed and found to be well attached to the dermis (Figure 7). 
Figure 7. Histological evaluation of the TE skin equivalent models incubated for 2 days in Green’s media and then 
for 12 days at the air-liquid interface. Black and green arrows indicate the dermal layer and differentiated 
epidermal layers, respectively. Scale bars represent 100 µm.
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3.3.2. The results of the endothelial outgrow from PHBV channels to 3D TE skin model
Following the encouraging results of HDMEC outgrowth through Matrigel®, PHBV scaffolds populated 
with HDMECs and HDFs were investigated for HDMECs outgrowth through reconstructed TE skin 
equivalent model.
Immunostained (Anti-human CD31) sections showed that HDMECs were evenly distributed within the 
channels and formed a monolayer, and the outer surface of the PHBV SVN was covered with HDFs 
(Figure 8). High magnification images of the immunostained sections revealed that the outgrowing 
cells from the PHBV channels towards the reconstructed skin models were CD31 positive HDMECs. 
The outgrowth of HDMECs was mostly observed from the connection edges of two separate 
electrospun sheets.
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Figure 8. H&E and immunostained (CD31 positive cells are shown with red colour) sections show that HDMECs 
were outgrowing from the PHBV channels towards the TE skin models. “e”, “d”, and “p” show epidermis, dermis, 
and PHBV SVN layers, respectively. The outgrowth was mostly observed from the connection edges of two 
separate electrospun sheets. Inclusion of VEGF in the growth medium enhanced the outgrowth distance of the 
HDMECs. The graph shows the quantification of the HDMEC outgrowth distance from PHBV SVN to TE skin 
models when the growth medium was supplemented with VEGF or non-supplemented as the control group. (*p 
≤ 0.05, n = 6). 
The results of the H&E and Anti-CD31 staining showed that the addition of VEGF to the growth media 
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The distance of migration went up to 121.7 ± 6.3 µm in the VEGF group when compared to non-
supplemented controls, where the outgrowth distance was 27.9 ± 11.9 µm. However, no cellular 
infiltration to the dermal layer of the implanted skin models was observed in any of the groups. 
3.3.3. The results of the vascularisation study of the TE skin model on CAM
In order to assess the effect of the presence of cells and pro-angiogenic factors on vascularisation of 
TE skin equivalents, DEDs and developed skin models were assessed using an ex-ovo CAM assay. The 
results showed that the mean number of blood vessels were the highest in 2dDR added TE skin 
equivalents, where the least blood vessels were observed in DED groups. The presence of dermal cells 
and the addition of both pro-angiogenic agents significantly increased the mean vessel count growing 
through the samples (Figure 9). 
Mean vessel counts for TE skin models when no pro-angiogenic agent added, when administered with 
2dDR and when administered with VEGF were 27.0 ± 1.3, 34.4 ± 1.9, and 45.6 ± 2.0, respectively 
whereas mean vessel count was 19.2 ± 1.5 for control DED group. None of the implanted groups 
affected the embryo survival rate, which was over 70% for each group. 
Although no complete integration was shown in any of the groups, DED only group was completely 
separable from CAM where TE skin samples either administered with VEGF or 2dDR were better 
attached to CAMs but without apparent tissue infiltration. 
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Figure 9. Representative macro images given in top row show the angiogenic activity of DED, TE skin only and TE 
skin with daily addition of 2dDR and VEGF. Histological appearance of the samples can be seen in the middle 
row. Black, red, green and blue arrows indicate the CAM, dermal layer, epidermal layer and blood vessels 
respectively. The graph in the bottom row demonstrates the quantification of blood vessels growing towards the 
samples. Scale bars for macro images and histological images represents 3 mm and 200 µm, respectively. 
(***p≤0.001, **p ≤ 0.01, n = 4).
4. Discussion
PHBV is a biocompatible polymer which is widely used in tissue engineering applications 35, and it has 
previously been reported as a suitable biomaterial to fabricate tissue engineering scaffolds using 
electrospinning 36. PHBV was chosen for the production of the vascular scaffolds not only due to the 
previous experiences of our research group 37–39, but also PHBV has previously been reported as a 
suitable host for supporting ECs to attach and proliferate on it and form a monolayer 40. Both 
electrospinning and 3D printing techniques have various advantages and are frequently used in tissue 
engineering applications. 3D printing technique allows controlling the production of a large number 
of scaffolds with exactly the same geometries in a short time while electrospinning enables to 
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fabricate scaffolds with a wide range of properties in terms of material composition, fibre diameter, 
thickness, porosity, and degradation rates 41–44. 
Accordingly, in this work, PHBV nanofibres were successfully manufactured via electrospinning, and 
alginate, a natural and biocompatible polysaccharide that is largely preferred for biomaterial 
applications 45,46, was used as a sacrificial substrate to create temporary support as interconnected 
networks. The perfusion of the channels with methylene blue dye showed that the channels were 
interconnected, and no leakage was observed neither between the two layers of electrospun PHBV 
nor through the small pores between fibres. The average fibre diameter and pore size were 0.76 ± 
0.22 µm and 2.73 ± 1.47 µm, respectively. PHBV fibres in these diameters have been shown to allow 
transportation of nutrients through fibres while preventing cells from escaping through them for up 
to 6 weeks 38,39. The suture retention test results demonstrated that the PHBV SVN was suitable to be 
used by suturing the tissue models onto the scaffold. The scaffolds were resistant to suture up to 1.70 
MPa and 0.89 MPa pull out strength, respectively under dry and wet conditions without any tearing. 
DuRaine et al. reported the suitability of their TE constructs with a suture retention strength of 1.45 
MPa for in vivo implantation by suturing them in place 47. Selders et al. demonstrated that the suture 
retention strength of the developed polymer templates was between 0.40 - 1.20 MPa under dry 
conditions 48. Similarly, Syedain et al. showed that acellular vascular grafts with a suture retention of 
approximately 0.15 MPa (reported as 175 g for a 12.1 mm2 graft area) were suitable for suturing in 
vivo as pulmonary artery replacements 49.
Nanofibres have been shown to provide better surface properties for ECs to adhere and proliferate 
on them over microfibres 50–52. This is likely due to the nanofibres being structurally similar to the ECM 
of natural tissue with their submicron-scale topography and highly packed morphology 50,53. 
Furthermore, PHBV nanofibres have previously been shown to be a suitable environment for ECs to 
form an endothelial monolayer 40. However, nanofibres also create a physical barrier for cells, which 
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limits the infiltration 54. Thus, prior to the outgrowth experiments, holes had to be pierced onto the 
channels of the scaffolds.  
This four-step manufacturing route allowed the production of a large number of identical vascular 
scaffolds in less than 2 hours. Similar fabrication routes of vascular scaffolds combining 
electrospinning and 3D printing have previously been reported. Jeffries et al. used 3D printed 
poly(vinyl alcohol) channels as a template in electrospun polydioxanone scaffolds to be used as a 
prevascularised implantable construct in future 55. Dew et al. previously reported the use of alginate 
as a sacrificial material in electrospun scaffolds and showed the successful endothelialisation of these 
scaffolds to study the factors that affect neovascularisation 37,40. However, none of these studies has 
gone further than studying only one aspect of angiogenesis at the cellular level and did not assess the 
potential of these scaffolds to be used with biologically relevant tissue models. In this study, we aimed 
to evaluate the potential use of these bioengineered vascular channels to be used to study 
angiogenesis in vitro and with complex tissue models in comparison with CAM, as a well-vascularised 
wound bed analogue, for the first time.
The results suggested that it was possible to cellularise the PHBV channels either with HDMECs in 
isolation or with HDMECs in the presence of HDFs which slightly improved the coverage of the 
channels with HDMECs as expected from the previously reported studies performed by other groups 
as well as our group 37,56. Although the coverage of the channels was not investigated quantitatively, 
the qualitative visualisation of the cell distribution within the channels showed almost a full coverage 
of the channels with HDMECs (Figure 5A-B). However, CellTracker™-labelled cellularisation results 
showed a more intermittent-like layer within the channel (Figure 5C). The most probable explanation 
for this is that CellTracker™ binds target DNA, and it is distributed equally between daughter cells after 
cell division 57. Although it is a very simple and rapid way of identifying different types of cells within 
a construct, we found that it is not highly effective for estimating the cellular confluency and for 
investigating the distribution of cells within the channels.
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Fibroblasts have previously been reported to play a key role in the angiogenic process by producing 
considerable amounts of ECM molecules (i.e. collagen, fibronectin and other molecules), growth and 
pro-angiogenic factors which control the shape and density of blood vessels 58,59. Although fibroblasts 
secrete some VEGF, the main role of these cells is to create an ECM in which endothelial cells can be 
embedded to form tubules. This ECM structure is rich in collagen I and fibronectin 60,61. PHBV SVN has 
been found to provide a suitable environment for HDMECs to form a monolayer either in the presence 
or absence of HDFs as helper cells. The use of HDFs was found to be desirable depending on the 
intended use of the PHBV SVN.
For the Matrigel® experiments, the PHBV SVN was cellularised with HDMECs in isolation, and the 
outgrowth of HDMECs was investigated towards the Matrigel®. The results showed that HDMECs were 
outgrowing and forming interconnected tube-like structures within the Matrigel® (either loaded with 
VEGF or 2dDR) close to edges of the pierced synthetic PHBV channels. The tube-like formed structures 
were more obvious and well-organised in VEGF loaded Matrigel® group when compared with 2dDR 
loaded and control groups. VEGF is an effective and well-established pro-angiogenic factor 62 which 
has been proven to be a regulator of EC proliferation, migration and survival 63,64. 2dDR, a small sugar 
that naturally occurs in the body as a result of the enzymatic degradation of thymidine to thymine 65, 
has recently been reported to have potential to induce angiogenesis in vitro 30, in ex ovo CAM assay 25, 
and in diabetic rats 66. 
The formation of the tube-like structures was pretty similar to those which can be observed in 
Matrigel® tube formation assays. In vivo, endothelial cells are in direct contact with a basement 
membrane which is specific and biologically functional for enabling endothelial cells to form tube 
structures 67. This biologically active protein mixture is a wonderful candidate for mimicking native 
basement membrane of endothelial cells in vitro and promotes endothelial cells to form tube-like 
capillary structures 68. Kubota et al. seeded endothelial cells on a mimicked basement membrane and 
reported that endothelial cells could attach and form tube-like capillary structures within 2-3 hours 69. 
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Our observations were in line with the literature where VEGF has been reported to regulate outgrowth 
of ECs 70–72. Loading of 2dDR into Matrigel® also stimulated ECs to form tube-like structures as we have 
previously reported the promotion of tube formation in Matrigel® assay 30. The proposed platform can 
be used to study more than one aspect of angiogenesis in vitro when combined with Matrigel®. 
However, several factors should be considered while using the developed model for the study of 
angiogenesis; 
(i) Matrigel® is a protein gel mixture which is rich in ECM proteins such as laminin, collagen heparin 
sulphate, proteoglycans etc. However, the exact concentrations of the ingredients are not clearly 
defined, and it shows high batch-to-batch variations 73. 
(ii) the thickness of Matrigel® should be considered as the thickness of gels has previously been shown 
to have a negative impact on the survival of ECs and HDFs 74.
(iii) HDMECs are very sensitive to culture conditions and show batch to batch variations 75. These 
variations of ECs have been previously shown to be a cause for not being reproducible for in vitro 
angiogenesis models 76.
(iv) the holes pierced on SVN channels were randomly oriented, and their positions and diameters 
might have an impact on the variations in the outgrowth of HDMECs. 
Following the Matrigel® experiments, a more physiologically relevant tissue model, TE skin model, was 
used with PHBV SVN to study vascularisation of a reconstructed human skin model. TE skin model was 
successfully developed using a well-established protocol 28. The air-liquid interface has previously 
been confirmed to provide a stimulus for the gradual differentiation of keratinocytes 23. The 
histological evaluation of the reconstructed TE skin models showed that developed TE skin model 
achieved a normal-looking gross skin morphology in 14 days. A multi-layered epithelium was formed 
and found to be well attached to the dermis. Following the reconstruction of TE skin, after 7-day 
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culture at the air-liquid interface, TE skin equivalent was attached to the top surface of the PHBV SVN 
and cultured for further 7 days at the air-liquid interface. 
The outgrowth of HDMECs towards the TE skin model was mostly observed from the connection edges 
of two separate electrospun sheets, and the inclusion of VEGF to the growth media significantly 
increased the outgrowth distance of HDMECs approximately 4.4-fold when compared to controls. 
However, cells were not found to be invading into the dermal layer of the developed skin models 
either supplemented with VEGF or not. Santos et al., previously demonstrated that starch-based 
scaffolds combined with growth factors and fibrin sealant (fibrinogen 75–115 mg/mL, thrombin 
4 IU/mL) were capable of promoting vascular infiltration to newly formed tissue in vivo 77. In addition, 
the concentration of fibrin glue used in this study is also approximately 3-4 times lower than some 
commercially available skin graft sealant fibrin glues 78,79. We have previously demonstrated that fibrin 
glue with a fibrinogen concentration of 18.75 mg/ml, a similarly high concentration as used in this 
study, did not hinder cell outgrowth from tissue explants 80. Thus, the concentration of fibrin glue does 
not seem to be the major cause of the prevention of cell penetration. The most probable explanations 
for this are that the outgrowth direction of HDMECs was against gravity; the rate of outgrowth of 
HDMECs from PHBV channels was low. Furthermore, the orientations, positions and diameters of the 
manually pierced random holes might also have negatively affected the outgrowth of HDMECs. Our 
group had previously explored the endothelialisation of a TE skin model and reported that the cells 
struggled to enter the TE skin and showed no signs of being organised when they did enter 24.
CAM is a well-vascularised membrane, and we hypothesised that CAM might represent a very well-
vascularised wound bed. Thus, as a positive control experiment, we implanted the TE skin models to 
assess the vascularisation of reconstructed skin models from CAM. The results of the ex-ovo CAM 
assay were in compliance with the results obtained from PHBV SVN studies. Although CAM is a highly 
vascularised and dynamic environment with fast proliferating embryonic cells 81, the results showed 
that there was no sign of blood vessel or tissue integration into the dermal layer of the reconstructed 
Page 32 of 58
ACS Paragon Plus Environment






























































skin substitutes. However, the presence of dermal cells (fibroblasts and keratinocytes) significantly 
improved the vascularisation in the area of implantation (towards the implanted TE skin) in 
comparison with DED (with no cells). In addition, the administration of VEGF and 2dDR showed a 
further increase in angiogenic activity. Although the major function of fibroblasts is to synthesise and 
maintain ECM structure, they have been reported to produce collagen, fibronectin, proteoglycans, 
and connective growth factors, especially in response to wounding 82,83. They have also been reported 
as producing soluble angiogenic growth factors such as VEGF 84, transforming growth factor-beta 
(TGF-β) 85, and Platelet-derived growth factor (PDGF) 86. Furthermore, keratinocytes have previously 
been reported to improve the proliferation of endothelial cells and to express VEGF 87. Recently, the 
presence of cells and in vitro generated ECM has also been shown to improve angiogenesis in the ex 
ovo CAM assay 88,89. The enhanced angiogenic properties of TE skin over DED on CAM might be 
validated by the studies given above. 
While an increased angiogenic activity was observed when cells and drugs were presented to CAMs, 
the histological evaluation of the implanted TE skin models showed that there was no tissue infiltration 
and vascularisation through the dermal layer of the reconstructed TE skin models. Although no 
vascularisation was observed in any of the implants, one important thing to note was that the inclusion 
of dermal cells (fibroblasts and keratinocytes) and pro-angiogenic agents (VEGF and 2dDR) improved 
the “take” of TE skin model by CAM when compared to DED with no cells. The attachment of TE skin 
model to CAM (either supplemented with pro-angiogenic agents or not) was stronger whereas the 
DED showed no integration with CAM, and it was easily separable from the surface of the membrane 
after the implantation period.
The developed platform showed encouraging results to be used as an in vitro platform to study 
angiogenesis either at cellular or tissue levels. Future studies need to be conducted to improve the 
reliability of the proposed in vitro platform to and to standardise the methodology for seeding of the 
cells, loading of Matrigel® to the synthetic vascular scaffolds, piercing holes, and assessing the 
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angiogenesis. In the scope of this study, only one tissue model was developed and assessed on PHBV 
SVN. However, promising results have shown that through further improvements, the PHBV SVN can 
offer a great platform for studying in vitro vascularisation of tissue models.
5. Conclusion
Herein we demonstrated the development of a polymeric vascular network to be used as an in vitro 
platform to study angiogenesis and to investigate the vascularisation of complex tissue models. The 
nanofibrous channels have been found to provide a suitable environment for HDMECs to form a 
monolayer either in the presence or absence of HDFs. The indirect co-culture with HDFs has been 
shown to be a desirable approach depending on the intended use of the PHBV SVN. The developed in 
vitro platform enabled the study of more than one aspect of angiogenesis (migration and tube 
formation) when combined with Matrigel®. In addition, PHBV SVN provided a convenient platform to 
study vascularisation of a reconstructed human skin model as a physiologically more relevant and 
complex structure. All these results demonstrated that the developed PHBV SVN could offer a really 
good platform to study angiogenesis in vitro with potential developments.
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Figure 1. Schematic illustration showing the four-step manufacturing process of synthetic vascular channels. 
(A) Electrospinning PHBV, (B) 3D printing of the sacrificial alginate channels, (C) electrospinning another 
layer of PHBV on top of alginate channels, and (D) removal of alginate. 
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Figure 2. Experiments showing the investigation of the potential of the PHBV SVN to be used as an in vitro 
platform to study angiogenesis and vascularisation of a TE skin model. Purple dotted lines represent pierced 
holes. Matrigel® and TE skin are indicated with blue and orange colours, respectively. 
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Figure 3. The macrostructure and the microstructure of the PHBV SVN scaffolds before and after removal of 
the 3D printed alginate. (A) Before removal of alginate, SEM images of the channels (top view), macro 
image of the PHBV SVN (top view), and dissection microscope image of the cross section of the channels, 
from left to right, respectively. (B) After removal of alginate, dissection microscope images of the methylene 
blue injected channels (top view), macro image of the methylene blue injected PHBV SVN channels (top 
view), and SEM image of the cross section of the channels, from left to right, respectively. 
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Figure 4. Fluorescent staining of sections taken from scaffolds recellularised with HDMECs in isolation. (A) 
DAPI (blue), (B) Phalloidin-TRITC (red) and (C) combined red and blue channels, and (D) H&E staining of 
the sections from PHBV SVN. 
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Figure 5. Recellularisation of the PHBV SVN with HDMECs and HDFs in indirect contact. (A) H&E staining of 
the HDMECs inside the channels and HDFs on the outer surface. (B) Immunostained sections of PHBV 
synthetic vascular scaffolds recellularised with HDMECS within the channels and HDFs on the outer surface. 
Cell nuclei was stained with DAPI (blue) and CD31+ cells were shown with red. (C) Sections of scaffolds with 
HDMECs labelled with CellTracker™Red inside the channels and HDFs labelled with CellTracker™Green on 
the outer surface of the scaffolds. 
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Figure 6. The figure shows the outgrowing HDMECs from PHBV channels to either plain or VEGF or 2dDR 
loaded Matrigel®. The ECs were stained with Phalloidin-TRITC (red) to visualise actin filaments and 
counterstained with DAPI (blue) to visualise the cell nuclei. Tube-like formed structures were obvious and 
well-organised in VEGF loaded Matrigel® groups when compared with 2dDR loaded and control groups. The 
graphs show the increase in the number of tubes formed (on the left) and branch points (on the right) 
within Matrigel® when VEGF and 2dDR were loaded. (***p≤0.001, *p ≤ 0.05). 
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Figure 7. Histological evaluation of the TE skin equivalent models incubated for 2 days in Green’s media and 
then for 12 days at the air-liquid interface. Black and green arrows indicate the dermal layer and 
differentiated epidermal layers, respectively. Scale bars represent 100 µm. 
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Figure 8. H&E and immunostained (CD31 positive cells are shown with red colour) sections show that 
HDMECs were outgrowing from the PHBV channels towards the TE skin models. “e”, “d”, and “p” show 
epidermis, dermis, and PHBV SVN layers, respectively. The outgrowth was mostly observed from the 
connection edges of two separate electrospun sheets. Inclusion of VEGF in the growth medium enhanced the 
outgrowth distance of the HDMECs. The graph shows the quantification of the HDMEC outgrowth distance 
from PHBV SVN to TE skin models when the growth medium was supplemented with VEGF or non-
supplemented as the control group. (*p ≤ 0.05, n = 6). 
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Figure 9. Representative macro images given in top row show the angiogenic activity of DED, TE skin only 
and TE skin with daily addition of 2dDR and VEGF. Histological appearance of the samples can be seen in the 
middle row. Black, red, green and blue arrows indicate the CAM, dermal layer, epidermal layer and blood 
vessels respectively. The graph in the bottom row demonstrates the quantification of blood vessels growing 
towards the samples. Scale bars for macro images and histological images represents 3 mm and 200 µm, 
respectively. (***p≤0.001, **p ≤ 0.01, n = 4). 
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